202 related articles for article (PubMed ID: 19123730)
1. Protocol for the examination of specimens from patients with ductal carcinoma in situ of the breast.
Lester SC; Bose S; Chen YY; Connolly JL; de Baca ME; Fitzgibbons PL; Hayes DF; Kleer C; O'Malley FP; Page DL; Smith BL; Weaver DL; Winer E;
Arch Pathol Lab Med; 2009 Jan; 133(1):15-25. PubMed ID: 19123730
[No Abstract] [Full Text] [Related]
2. Coronal serial sequential sampling of breast specimen in the assessment of the extent of ductal carcinoma in situ.
Mai KT; Stinson WA; Burns BF
Arch Pathol Lab Med; 2009 Sep; 133(9):1362; author reply 1362-3. PubMed ID: 19722734
[No Abstract] [Full Text] [Related]
3. Examination of specimens from patients with ductal carcinoma in situ of the breast using large-format histology sections.
Tot T; Ibarra JA
Arch Pathol Lab Med; 2009 Sep; 133(9):1361; author reply 1361-2. PubMed ID: 19722732
[No Abstract] [Full Text] [Related]
4. True colors.
Ginter P; Jones JG; Hoda SA
Int J Surg Pathol; 2011 Aug; 19(4):494-6. PubMed ID: 21665859
[No Abstract] [Full Text] [Related]
5. Measurement of whole tumour size in breast cancer specimens.
Littleford S; Carder PJ
Histopathology; 2005 Nov; 47(5):543-4. PubMed ID: 16242009
[No Abstract] [Full Text] [Related]
6. A practical approach to breast ductal carcinoma in situ and tumors with an extensive intraductal component.
King JM
Pathology; 1994 Apr; 26(2):90-3. PubMed ID: 8090601
[TBL] [Abstract][Full Text] [Related]
7. Protocol for the examination of specimens from patients with carcinoma of the urethra.
McKenney JK; Amin MB; Epstein JI; Grignon DJ; Oliva E; Reuter VE; Srigley JR; Humphrey PA
Arch Pathol Lab Med; 2010 Mar; 134(3):345-50. PubMed ID: 20196662
[No Abstract] [Full Text] [Related]
8. Protocol for the examination of specimens removed from patients with carcinoma of the exocrine pancreas: a basis for checklists. Cancer Committee, College of American Pathologists.
Compton CC; Henson DE
Arch Pathol Lab Med; 1997 Nov; 121(11):1129-36. PubMed ID: 9372738
[No Abstract] [Full Text] [Related]
9. College of American Pathologists protocol for the reporting of ductal carcinoma in situ.
Lester SC; Connolly JL; Amin MB
Arch Pathol Lab Med; 2009 Jan; 133(1):13-4. PubMed ID: 19123725
[No Abstract] [Full Text] [Related]
10. Protocol for the examination of specimens from patients with merkel cell carcinoma of the skin.
Rao P; Balzer BL; Lemos BD; Liegeois NJ; McNiff JM; Nghiem P; Prieto VG; Smith MT; Smoller BR; Wick MR; Frishberg DP
Arch Pathol Lab Med; 2010 Mar; 134(3):341-4. PubMed ID: 20196661
[No Abstract] [Full Text] [Related]
11. Comparative analysis of size estimation by mapping and counting number of blocks with ductal carcinoma in situ in breast excision specimens.
Dadmanesh F; Fan X; Dastane A; Amin MB; Bose S
Arch Pathol Lab Med; 2009 Jan; 133(1):26-30. PubMed ID: 19123732
[TBL] [Abstract][Full Text] [Related]
12. Protocol for the examination of specimens from patients with hematopoietic neoplasms of the ocular adnexa.
Bradley KT; Arber DA; Brown MS; Chang CC; Coupland SE; de Baca ME; Ellis DW; Foucar K; Hsi ED; Jaffe ES; Lill MC; McClure SP; Medeiros LJ; Perkins SL; Hussong JW
Arch Pathol Lab Med; 2010 Mar; 134(3):336-40. PubMed ID: 20196660
[No Abstract] [Full Text] [Related]
13. Protocol for the examination of specimens from patients with invasive carcinoma of the breast.
Lester SC; Bose S; Chen YY; Connolly JL; de Baca ME; Fitzgibbons PL; Hayes DF; Kleer C; O'Malley FP; Page DL; Smith BL; Tan LK; Weaver DL; Winer E;
Arch Pathol Lab Med; 2009 Oct; 133(10):1515-38. PubMed ID: 19792042
[No Abstract] [Full Text] [Related]
14. [Pathological findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Intraductal carcinoma (ductal carcinoma in situ)].
Haase W
Strahlenther Onkol; 1996 Feb; 172(2):109-10. PubMed ID: 8669043
[No Abstract] [Full Text] [Related]
15. Protocol for the examination of specimens removed from patients with esophageal carcinoma. A basis for checklists. The Cancer Committee, College of American Pathologists, and the Task Force on the Examination of Specimens From Patients With Esophageal Cancer.
Lee RG; Compton CC
Arch Pathol Lab Med; 1997 Sep; 121(9):925-9. PubMed ID: 9302923
[No Abstract] [Full Text] [Related]
16. Protocol for the examination of specimens from patients with hematopoietic neoplasms of the bone marrow: a basis for checklists.
Peterson LC; Agosti SJ; Hoyer JD; ;
Arch Pathol Lab Med; 2002 Sep; 126(9):1050-6. PubMed ID: 12240626
[No Abstract] [Full Text] [Related]
17. [Management of ductal carcinoma in situ by the pathologist: current questions].
Arnould L; Caron Y; Sigal-Zafrani B
Ann Pathol; 2003 Dec; 23(6):534-46. PubMed ID: 15094591
[TBL] [Abstract][Full Text] [Related]
18. Margins in ductal carcinoma in situ: is bigger really better?
Morrow M; Katz SJ
J Natl Cancer Inst; 2012 Apr; 104(7):494-5. PubMed ID: 22440679
[No Abstract] [Full Text] [Related]
19. Percentage of blocks with DCIS.
Goldstein N
Breast Cancer Res Treat; 2001 Feb; 65(3):259. PubMed ID: 11336248
[No Abstract] [Full Text] [Related]
20. Assessment of treatment for patients with primary ductal carcinoma in situ in the breast.
Gump FE
Ann Surg Oncol; 1999; 6(5):510-1. PubMed ID: 10458692
[No Abstract] [Full Text] [Related]
[Next] [New Search]
